S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|NPS Pharma Reports Third-Quarter 2014 Financial Results|
|NPS Pharma Stock Trading Halted Today; FDA Advisory Committee to Review Natpara® Biologics License Application|
|NPS Pharma Appoints Pierre Legault to Board of Directors|
|Teduglutide Granted Orphan Drug Designation in Japan|
|FDA Posts Briefing Materials for Advisory Committee Meeting Reviewing Natpara® for Hypoparathyroidism|
|PDUFA Action Date for Natpara® BLA Extended Three Months to January 24, 2015|
|FDA Advisory Committee Recommends Approval of Natpara® for Long-Term Treatment of Hypoparathyroidism|
|NPS Pharma to Report Third Quarter 2014 Financial Results|
|NPS Pharma to Present at Leerink Partners Rare Disease Roundtable|
|NPS Pharma to Present at Jefferies Global Healthcare Conference|
Click above to view more mutual fund data and stats for npsp - NPS Pharmaceuticals Inc.